175 related articles for article (PubMed ID: 11566347)
21. Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia.
Farra C; Awwad J; Valent A; Lozach F; Bernheim A
Cancer Genet Cytogenet; 2004 Dec; 155(2):138-42. PubMed ID: 15571799
[TBL] [Abstract][Full Text] [Related]
22. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD
Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
[TBL] [Abstract][Full Text] [Related]
23. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
24. AML1 fusion transcripts in t(3;21) positive leukemia: evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts.
Sacchi N; Nisson PE; Watkins PC; Faustinella F; Wijsman J; Hagemeijer A
Genes Chromosomes Cancer; 1994 Dec; 11(4):226-36. PubMed ID: 7533526
[TBL] [Abstract][Full Text] [Related]
25. Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML.
Cuenco GM; Nucifora G; Ren R
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1760-5. PubMed ID: 10677531
[TBL] [Abstract][Full Text] [Related]
26. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.
Mitani K; Ogawa S; Tanaka T; Miyoshi H; Kurokawa M; Mano H; Yazaki Y; Ohki M; Hirai H
EMBO J; 1994 Feb; 13(3):504-10. PubMed ID: 8313895
[TBL] [Abstract][Full Text] [Related]
27. A new translocation that rearranges the AML1 gene in a patient with T-cell acute lymphoblastic leukemia.
Mikhail FM; Serry KA; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Coignet L; Nucifora G
Cancer Genet Cytogenet; 2002 May; 135(1):96-100. PubMed ID: 12072207
[TBL] [Abstract][Full Text] [Related]
28. Unusual Karyotype in Acute Myelomonocitic Leukemia: A Case Report.
Consoli ML; Romano A; Parrinello NL; Tambè L; Romeo MA; Salemi D; Santoro A; DI Raimondo F
Anticancer Res; 2019 Aug; 39(8):4329-4332. PubMed ID: 31366525
[TBL] [Abstract][Full Text] [Related]
29. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.
Cuenco GM; Ren R
Oncogene; 2004 Jan; 23(2):569-79. PubMed ID: 14724585
[TBL] [Abstract][Full Text] [Related]
30. Identification of two new translocations that disrupt the AML1 gene.
Richkind K; Hromas R; Lytle C; Crenshaw D; Velasco J; Roherty S; Srinivasiah J; Varella-Garcia M
Cancer Genet Cytogenet; 2000 Oct; 122(2):141-3. PubMed ID: 11106827
[TBL] [Abstract][Full Text] [Related]
31. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
[TBL] [Abstract][Full Text] [Related]
32. Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.
Tsukamoto N; Karasawa M; Tanaka Y; Yokohama A; Uchiumi H; Matsushima T; Murakami H; Nojima Y
Int J Hematol; 2003 Nov; 78(4):362-9. PubMed ID: 14686496
[TBL] [Abstract][Full Text] [Related]
33. [Detection of t(3 ; 21) (q26 ; q22) with AML1/EVI1 mRNA during progression of myelodysplastic syndrome to acute myeloid leukemia].
Choi I; Goto T; Nagano M; Muta K; Yufu Y; Uike N; Kozuru M; Abe Y; Nisimura J
Rinsho Ketsueki; 1999 Jun; 40(6):518-20. PubMed ID: 10422292
[TBL] [Abstract][Full Text] [Related]
34. Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia.
Mathew S; Head D; Rubnitz JE; Raimondi SC
Genes Chromosomes Cancer; 2000 Jun; 28(2):227-32. PubMed ID: 10825008
[TBL] [Abstract][Full Text] [Related]
35. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
[TBL] [Abstract][Full Text] [Related]
36. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
37. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
[TBL] [Abstract][Full Text] [Related]
38. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
Kwong YL; Chan V; Wong KF; Chan TK
Cancer; 1995 Feb; 75(3):821-5. PubMed ID: 7828132
[TBL] [Abstract][Full Text] [Related]
39. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.
Yergeau DA; Hetherington CJ; Wang Q; Zhang P; Sharpe AH; Binder M; Marín-Padilla M; Tenen DG; Speck NA; Zhang DE
Nat Genet; 1997 Mar; 15(3):303-6. PubMed ID: 9054947
[TBL] [Abstract][Full Text] [Related]
40. Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.
Zhang Y; Strissel P; Strick R; Chen J; Nucifora G; Le Beau MM; Larson RA; Rowley JD
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3070-5. PubMed ID: 11867721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
